MTHFD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.06740172256536E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.60759999984417E-07 |
Normal-vs-Stage2 |
6.00149929752547E-11 |
Normal-vs-Stage3 |
1.15574216863479E-13 |
Normal-vs-Stage4 |
4.20160000014214E-07 |
Stage1-vs-Stage2 |
3.900600E-03 |
Stage1-vs-Stage3 |
2.45419999999053E-05 |
Stage1-vs-Stage4 |
5.652000E-02 |
Stage2-vs-Stage3 |
7.820200E-01 |
Stage2-vs-Stage4 |
5.255000E-01 |
Stage3-vs-Stage4 |
3.563800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.0328963219215E-11 |
Normal-vs-AfricanAmerican |
3.00709457334847E-11 |
Normal-vs-Asian |
4.818400E-02 |
Caucasian-vs-AfricanAmerican |
2.384000E-02 |
Caucasian-vs-Asian |
6.874200E-01 |
AfricanAmerican-vs-Asian |
1.810010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.34694510889722E-12 |
Normal-vs-Female |
1.15560000457648E-08 |
Male-vs-Female |
2.000600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.55329999995679E-06 |
Normal-vs-Age(41-60Yrs) |
1.75409999858545E-08 |
Normal-vs-Age(61-80Yrs) |
2.23400187238099E-11 |
Normal-vs-Age(81-100Yrs) |
2.05759999999389E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.592800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.656600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.235600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.152390E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.436600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.853600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.320600E-01 |
Normal-vs-Grade 2 |
1.01499999960453E-07 |
Normal-vs-Grade 3 |
1.18919984970489E-10 |
Normal-vs-Grade 4 |
8.65210014744378E-10 |
Grade 1-vs-Grade 2 |
1.450360E-01 |
Grade 1-vs-Grade 3 |
6.446000E-02 |
Grade 1-vs-Grade 4 |
1.855620E-02 |
Grade 2-vs-Grade 3 |
1.410200E-01 |
Grade 2-vs-Grade 4 |
2.735800E-03 |
Grade 3-vs-Grade 4 |
3.106100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.717100E-03 |
Normal-vs-ccB subtype |
1.62436730732907E-12 |
ccA subtype-vs-ccB subtype |
1.62436730732907E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.67149993635496E-10 |
Normal-vs-N1 |
1.84509999501259E-08 |
N0-vs-N1 |
9.555800E-03 |
|
|